A new RNA partnership hunts rare epilepsies; AbbVie and I-Mab tackle CD47
Zogenix is getting a new partner as it looks to tackle rare childhood seizures.
The California-based biotech, which developed and produces the seizure drug Fintepla …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
